Filing Details
- Accession Number:
- 0001209191-22-008980
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-11 18:08:52
- Reporting Period:
- 2022-02-09
- Accepted Time:
- 2022-02-11 18:08:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1595893 | Turning Point Therapeutics Inc. | TPTX | Pharmaceutical Preparations (2834) | 463826166 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1654482 | Mohammad Hirmand | 10628 Science Center Drive San Diego CA 92121 | Evp & Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-02-09 | 669 | $36.30 | 6,838 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-02-09 | 18,983 | $0.00 | 25,821 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2022-02-09 | 15,000 | $0.00 | 40,821 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | A | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2022-02-09 | 68,367 | $0.00 | 68,367 | $37.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 68,367 | 2032-02-08 | No | 4 | A | Direct |
Footnotes
- Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to Reporting Person on February 8, 2021.
- The Reporting Person acquired 301 shares on June 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan (the "ESPP") and 439 shares on December 10, 2021 pursuant to the ESPP.
- Represents restricted stock unit award granted under the Issuer's 2019 Equity Plan.
- 1/48th of the shares vest monthly following February 9, 2022.
Billionaire Hedge Funds
